What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?
Journal of Gastroenterology · 2024
DOI: 10.1007/s00535-024-02105-y ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Yuichi Kano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Cholangitis, Sclerosing, Bile Duct Neoplasms, Cholangiopancreatography, Endoscopic Retrograde. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: In primary sclerosing cholangitis (PSC), it is important to understand the cholangiographic findings suggestive of malignancy, but it is difficult to determine whether cholangiocarcinoma is present due to modifications caused by inflammation. This study aimed to clarify the appropriate method of pathological specimen collection during endoscopic retrograde cholangiopancreatography for surveillance of PSC. METHODS: A retrospective observational study was performed on 59 patients with PSC. The endpoints were diagnostic performance for benign or malignant on bile cytology and transpapillary bile duct biopsy, cholangiographic findings of biopsied bile ducts, diameters of the strictures and upstream bile ducts, and their differences. RESULTS: The sensitivity (77.8% vs. 14.3%, P = 0.04), specificity (97.8% vs. 83.0%, P = 0.04), and accuracy (94.5% vs. 74.1%, P = 0.007) were all significantly greater for bile duct biopsy than for bile cytology. All patients with cholangiocarcinoma with bile duct stricture presented with dominant stricture (DS). The diameter of the upstream bile ducts (7.1 (4.2-7.2) mm vs. 2.1 (1.2-4.1) mm, P < 0.001) and the diameter differences (6.6 (3.1-7) mm vs. 1.5 (0.2-3.6) mm, P < 0.001) were significantly greater in the cholangiocarcinoma group than in the noncholangiocarcinoma group with DS. For diameter differences, the optimal cutoff value for the diagnosis of benign or malignant was 5.1 mm (area under the curve = 0.972). CONCLUSION: Transpapillary bile duct biopsy should be performed via localized DS with upstream dilation for the detection of cholangiocarcinoma in patients with PSC. Especially when the diameter differences are greater than 5 mm, the development of cholangiocarcinoma should be strongly suspected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan.
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan. ishitaku@med.nagoya-u.ac.jp.
- Department of Endoscopy, Nagoya University Hospital, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan.
ORCID-Profile: Takuya Ishikawa
Zitieren
APA
Kano, Y., Ishikawa, T., Yamao, K., Mizutani, Y., Iida, T., Uetsuki, K., Yamamura, T., Furukawa, K., Nakamura, M., & Kawashima, H. (2024). What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02105-y
Vancouver
Kano Y, Ishikawa T, Yamao K, Mizutani Y, Iida T, Uetsuki K, et al. What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?. Journal of Gastroenterology. 2024. doi:10.1007/s00535-024-02105-y
BibTeX
@article{Kano2024,
author = {Kano, Yuichi and Ishikawa, Takuya and Yamao, Kentaro and Mizutani, Yasuyuki and Iida, Tadashi and Uetsuki, Kota and Yamamura, Takeshi and Furukawa, Kazuhiro and Nakamura, Masanao and Kawashima, Hiroki},
title = {What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?},
journal = {Journal of Gastroenterology},
year = {2024},
doi = {10.1007/s00535-024-02105-y}
}
EUVIMED